Preserved ratio impaired spirometry and restrictive spirometric pattern in obese populations: Clinical relevance with
Yuhan Wang1, Hailing Liu1, Jingyi Zhang1
1Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Objective:
Obesity hypoventilation syndrome is defined as daytime hypercapnia in obese individuals without other underlying causes, associated with reduced lung volume. Preserved ratio impaired spirometry (PRISm) and restrictive spirometric pattern (RSP) are different spirometry patterns. In this pilot study, we investigated the association between PRISm (with or without RSP) and daytime hypercapnia in obese patients.
Methods:
We conducted a cross-sectional study in 106 obese patients (body mass index ≥ 30 kg/m2). Daytime hypercapnia was defined as an arterial carbon dioxide partial pressure (PaCO2) > 45 mmHg based on arterial blood gas analysis. PRISm was defined as FEV1/FVC ≥ 0.70 and FEV1 < 80 % predicted, and RSP was defined as FEV1/FVC ≥ 0.70 and FVC < 80 % predicted. We categorized PRISm and RSP into mutually exclusive groups (normal, PRISm alone, RSP alone, and PRISm + RSP).
Results:
Among the 106 obese patients (mean age 47.5 ± 14.0 years, 65.1 % male), 30 (28.3 %) had daytime hypercapnia. The prevalence of daytime hypercapnia was 23.5 % (16/68) in the normal spirometry group, 63.6 % (7/11) in the PRISm alone group, and 23.1 % (6/26) in the PRISm + RSP group. In multivariable logistic regression analyses, after adjusting for age, sex, body mass index, ever smoking, apnea-hypopnea index, mean oxygen saturation by pulse oximetry, and FEV1, PRISm alone was independently associated with daytime hypercapnia (P = 0.043).
Conclusions:
Our study observed an association between non-restrictive PRISm and daytime hypercapnia in obese patients. Further research is needed to elucidate the underlying mechanisms and clinical significance of this association.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...